AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
Go back to AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026| (NASDAQ: ACIU) | Delayed: 2.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $19.97 | |||
| Open | $2.51 | 52 Week Low | $10.36 | |||
| Day High | $2.51 | P/E | N/A | |||
| Day Low | $2.51 | EPS | $0.00 | |||
| Volume | 5 | |||||

